Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, with reference to the report of the independent cancer taskforce, Achieving world class cancer outcomes: A strategy for England 2015-2020, published in July 2015, what progress NHS England has made in putting a mandate in place to ensure that GPs have direct access to key investigative tests for suspected cancers.

The Independent Cancer Taskforce’s five-year strategy Achieving World-class Cancer Outcomes A Strategy for England 2015-2020 recommends improvements across the cancer pathway, including improved access to investigative testing.

We have already announced funding of up to £300 million a year by 2020 to increase diagnostic capacity to meet the new target that patients will be given a definitive cancer diagnosis, or the all clear, within 28 days of being referred by a general practitioner (GP). The NHS National Cancer Director has set up a new Cancer Transformation Board to lead the roll-out of the recommendations of the new strategy, and a Cancer Advisory Group, chaired by Dr Harpal Kumar, Chief Executive of Cancer Research UK, will oversee and scrutinise their work.

The National Institute for Health and Care Excellence Suspected cancer: recognition and referral guideline which was published in June 2015 includes recommendations regarding when GPs should refer patients for direct access investigative tests. NHS England expects clinical commissioning groups to enable GPs to follow the guideline.